Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

BIT225-012 Phase 2 COVID-19 Clinical Trial

6 September 2024 by Audrey Thomson

BIT225-012 Phase 2 COVID-19 Clinical Trial

Categories 2024, ASX Announcements

Corporate Governance Statement 2024

Biotron Response to ASX Aware Query

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 24 April 2025 Legal Notices and Privacy